Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by steve957on Jul 25, 2018 11:19am
111 Views
Post# 28364744

YOU THINK SERRUYA IS HOLDING THIS GARBAGE LOL

YOU THINK SERRUYA IS HOLDING THIS GARBAGE LOLWITH YOUR CASH !!!!!! WHAT A FUKCING JOKE 4 MONTH HOLD ON THE FIRST TWO PLACEMENTS,,,,,, SERRUYA HAVE SOLD THERE FIRST TWO PLACEMENTS AND ARE HOLDING SMALL BAG FROM THE MOST RECENT PRIVATE PLACEMENT AT 0.73 CENTS!!!!! 

Aaron Nathaniel Serruya of Serruya Equity stated, “We are pleased to participate in yet another round of funding for Isodiol. Isodiol continues to impress us with innovation and global reach. We expect great things from the Company, including their recent successful launch of a non-cannabis based CBD derived from two specific strains of hops and their pending acquisition of Biosynthesis Pharma Group


The securities issued in connection with the Offering will be subject to a hold period of four months plus a day from the date of issuance pursuant to applicable securities laws.
Read more at https://www.stockhouse.com/news/press-releases/2017/12/19/isodiol-international-inc-announces-strategic-30-000-000-cad-financing#tkrfFubaKl4Vlr7F.99
Bullboard Posts